A Novel Simultaneous Determination of Sarpogrelate and its Active Metabolite (M-1) in Human Plasma, Using Liquid Chromatography-Tandem Mass Spectrometry: Clinical Application

about

Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans

P2860

Q37265701-4C80B6AB-3A11-481C-815C-BFF4C3DBE53A

P2860

A Novel Simultaneous Determination of Sarpogrelate and its Active Metabolite (M-1) in Human Plasma, Using Liquid Chromatography-Tandem Mass Spectrometry: Clinical Application

Item

http://www.wikidata.org/entity/Q41200449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Novel Simultaneous Determina ...... trometry: Clinical Application

@en

type

Item

label

A Novel Simultaneous Determina ...... trometry: Clinical Application

@en

prefLabel

A Novel Simultaneous Determina ...... trometry: Clinical Application

@en

P1476

A Novel Simultaneous Determina ...... trometry: Clinical Application

@en

P2093

EunGi Cho

http://www.w3.org/2001/XMLSchema#string

Jae-Wook Ko

http://www.w3.org/2001/XMLSchema#string

Jeong-Soo Yang

http://www.w3.org/2001/XMLSchema#string

Jung-Ryul Kim

http://www.w3.org/2001/XMLSchema#string

Soo-Youn Lee

http://www.w3.org/2001/XMLSchema#string

Wooseong Huh

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid chromatography tandem mass spectrometry method for the quantification of sarpogrelate, a selective 5-HT(₂A) receptor antagonist, in plasma: application to a pre-clinical pharmacokinetic study.

Therapeutic potentials of sarpogrelate in cardiovascular disease.

Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.

Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes.

Validated LC-MS/MS method for the determination of sarpogrelate in human plasma: application to a pharmacokinetic and bioequivalence study in Chinese volunteers.

Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.

Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.

Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl o

P304

391-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3343/ALM.2015.35.4.391

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277961966

http://www.w3.org/2001/XMLSchema#string

P698

26131409

http://www.w3.org/2001/XMLSchema#string

P932

4446576

http://www.w3.org/2001/XMLSchema#string

A Novel Simultaneous Determination of Sarpogrelate and its Active Metabolite (M-1) in Human Plasma, Using Liquid Chromatography-Tandem Mass Spectrometry: Clinical Application

about

P2860

P2860

A Novel Simultaneous Determination of Sarpogrelate and its Active Metabolite (M-1) in Human Plasma, Using Liquid Chromatography-Tandem Mass Spectrometry: Clinical Application

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932